AAL
47
-3
NTRS
47
-2
AN
49
2
AEE
61
-2
JBHT
49
3
HES
59
3
MS
50
-8
SO
64
-2
GRMN
50
-2
CTAS
56
-5
BAC
39
-2
DLTR
31
3
VRSN
50
-5
ED
53
-5
SYK
57
-2
SE
65
4
STZ
54
-4
UHS
58
4
PYPL
45
-2
CCL
71
4
AAL
47
-3
NTRS
47
-2
AN
49
2
AEE
61
-2
JBHT
49
3
HES
59
3
MS
50
-8
SO
64
-2
GRMN
50
-2
CTAS
56
-5
BAC
39
-2
DLTR
31
3
VRSN
50
-5
ED
53
-5
SYK
57
-2
SE
65
4
STZ
54
-4
UHS
58
4
PYPL
45
-2
CCL
71
4
Financhill
Back

Trinity Biotech PLC 10K Form

Sell
3

TRIB
Trinity Biotech PLC

Last Price:
1.25
Seasonality Move:
-5.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TRIB News And Ratings

See the #1 stock for the next 7 days that we like better than TRIB

TRIB Financial Statistics

Sales & Book Value

Annual Sales: $56.83M
Cash Flow: $-4.27M
Price / Cash Flow: 0
Annual Sales: $-3.11
Price / Book: 0

Profitability

EPS (TTM): -2.68300
Net Income (TTM): $-22.3M
Gross Margin: $19.45M
Return on Equity: 0%
Return on Assets: -29.36%

Trinity Biotech PLC Earnings Forecast

Key Trinity Biotech PLC Financial Ratios

  • The Gross Profit Margin over the past 30 years for TRIB is 34.22%.
  • The Selling, General & Administrative Expenses for TRIB have been equal to 54.81% of Gross Profit Margin.
  • The Research & Development expenses have been 7.71% of Revenue.
  • The Interest Expense is -42.25% of Operating Income.
  • The Net Earning history of TRIB is -42.26% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 15 years.

Trinity Biotech PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: TRIB
CUSIP: 896438
Website: trinitybiotech.com

Debt

Debt-to-Equity Ratio: -2.75
Current Ratio: 1.78
Quick Ratio: 0.89

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TRIB Technical Analysis vs Fundamental Analysis

Sell
3
Trinity Biotech PLC (TRIB) is a Sell

Is Trinity Biotech PLC a Buy or a Sell?